1. Homepage
  2. Equities
  3. Germany
  4. Xetra
  5. Sartorius AG
  6. Summary
    SRT   DE0007165607

SARTORIUS AG

(SRT)
  Report
Real-time Estimate Tradegate  -  05/20 03:29:32 pm EDT
313.00 EUR   -2.19%
05/19Sartorius Announces Further Growing its Global Production Capacity with Expansion of its Manufacturing Site in Tunisia
CI
05/16SARTORIUS VORZUEGE : UBS takes a positive view
MD
04/26SARTORIUS VORZUEGE : Warburg Research reaffirms its Buy rating
MD
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Xetra
05/16/2022 05/17/2022 05/18/2022 05/19/2022 05/20/2022 Date
324(c) 322.5(c) 313(c) 320(c) 317 Last
3 729 1 709 3 537 2 180 2 217 Volume
+6.58% -0.46% -2.95% +2.24% -0.94% Change
More quotes
Estimated financial data (e)
Sales 2022 4 139 M 4 382 M 4 382 M
Net income 2022 574 M 608 M 608 M
Net Debt 2022 1 457 M 1 543 M 1 543 M
P/E ratio 2022 35,8x
Yield 2022 0,37%
Sales 2023 4 512 M 4 777 M 4 777 M
Net income 2023 642 M 680 M 680 M
Net Debt 2023 1 011 M 1 071 M 1 071 M
P/E ratio 2023 33,9x
Yield 2023 0,37%
Capitalization 22 519 M 23 842 M 23 842 M
EV / Sales 2022 5,79x
EV / Sales 2023 5,21x
Nbr of Employees 15 051
Free-Float 33,3%
More Financials
Company
Sartorius AG specializes in the design, manufacturing and marketing of medical equipments for the pharmaceutical, chemical and food processing industries. The group also develops mechatronic instruments for industrial and laboratory applications. Net sales break down by family of products as follows: - biotechnological equipments (76.3%): fermentation, filtration, process, membrane chromatography and fluids storage... 
More about the company
Ratings of Sartorius AG
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
A-
More Ratings
All news about SARTORIUS AG
05/19Sartorius Announces Further Growing its Global Production Capacity with Expansion of it..
CI
05/16SARTORIUS VORZUEGE : UBS takes a positive view
MD
04/26SARTORIUS VORZUEGE : Warburg Research reaffirms its Buy rating
MD
04/22SARTORIUS VORZUEGE : JP Morgan reiterates its Buy rating
MD
04/22SARTORIUS VORZUEGE : Deutsche Bank maintains a Buy rating
MD
04/22SARTORIUS VORZUEGE : Berenberg maintains a Buy rating
MD
04/21TRANSCRIPT : Sartorius Aktiengesellschaft, Q1 2022 Earnings Call, Apr 21, 2022
CI
04/21SARTORIUS : Conference Call Q1|2022 Presentation
PU
04/21SARTORIUS VORZUEGE : Gets a Buy rating from Berenberg
MD
04/21SARTORIUS VORZUEGE : UBS sticks Neutral
MD
04/21Sartorius Aktiengesellschaft Reports Earnings Results for the First Quarter Ended March..
CI
04/21Sartorius Shares Rise After Strong 1Q Results
DJ
04/21Sartorius sticks to 2022 outlook despite rising costs, Ukraine
RE
04/21Sartorius' Q1 Profit Climbs 38% On Strong Demand, High Order Intake
MT
04/21SARTORIUS AG : 1st quarter results
CO
More news
News in other languages on SARTORIUS AG
05/19Sartorius annonce une nouvelle augmentation de sa capacité de production mondiale avec ..
05/16ACTUALIZACIÓN DE LAS GRANDES EVOLUCI : las autoridades polacas hacen caer a dos suizos, HS..
05/16XETRA-SCHLUSS/DAX verpatzt Start in die Woche - Sommerloch droht
05/16POINT SUR LES FORTES VARIATIONS DU J : les autorités polonaises font chuter deux Suisses, ..
05/16MÄRKTE EUROPA/Berg und Talfahrt hält an - Valneva brechen ein
More news
Analyst Recommendations on SARTORIUS AG
More recommendations
Stock Trading Strategies
SARTORIUS AG - 2021
No turn-around in sight
BUY
More Stock Trading Analysis
Chart SARTORIUS AG
Duration : Period :
Sartorius AG Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends SARTORIUS AG
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 7
Last Close Price 320,00 €
Average target price 443,55 €
Spread / Average Target 38,6%
EPS Revisions
Managers and Directors
Joachim Kreuzburg Chief Executive Officer
Rainer Lehmann Chief Financial Officer
Lothar Kappich Chairman-Supervisory Board
Oscar-Werner Reif Head-Research & Development
Volker Niebel Head-Production, Procurement & Business Operations
Sector and Competitors
1st jan.Capi. (M$)
SARTORIUS AG-35.87%23 842
REVENIO GROUP OYJ-17.62%1 287
BIOTAGE AB (PUBL)-27.06%1 272
VAREX IMAGING CORPORATION-29.64%884
CELLAVISION AB (PUBL)5.78%828
908 DEVICES INC.-40.82%481